SMYD2 and chronic kidney disease: Collectively, our findings from both in vivo and in vitro models demonstrate that SMYD2 drives renal tubular epithelial cell apoptosis in cisplatin‐induced CKD by mediating activation of the NF‐κB signaling pathway.